apollo
logo
0

Welcome User

Login/Sign Up

Home
Buy Medicines
Lab Tests
Doctor Consult
Circle Membership
insurance
Blogs
Contact Us
Privacy Policy
Return & Refunds
Need Help
Terms and Conditions
Select Delivery Location
compositionComposition:TIRZEPATIDE-5MG
prescription
Prescription Medicine
info
image icons
image icons
image icons
Best Price

₹14515 with coupons & bank offers*

View

Yurpeak 5 mg/0.6ml Kwikpen is used to treat type II diabetes. It is also used to treat obesity. It contains Tirzepatide, which works by increasing insulin levels, slowing gastric emptying. This medicine may cause side effects such as vomiting, nausea, abdominal pain, diarrhoea, headache and allergic reactions. Each KwikPen delivers four doses, offering convenient once-weekly administration for a full month's treatment.

Read more
Written By Lakshmithulasi Yarragunta , PharmD (PB)
Reviewed By Dr Aneela Siddabathuni , MPharma., PhD
OffersOffers & Discounts

Get Free delivery (₹99) with circle icon

Join Circle
Get 10% Off with Coupons
Extra 10% Off with Bank Offers
bank offer
bank offer
bank offer

More about the Product

Composition :

TIRZEPATIDE-5MG

Manufacturer/Marketer :

Cipla Ltd

Consume Type :

Parenteral

Expires on or after :

Dec-28

Return Policy :

Not Returnable

About Yurpeak 5 mg/0.6ml Kwikpen

Yurpeak 5 mg/0.6ml Kwikpen is used to treat type II diabetes. Type II diabetes mellitus is a condition in which the body does not use insulin effectively, leading to abnormal blood glucose levels. Tirzepatide is also used in combination with other medicines to treat obesity.

Yurpeak 5 mg/0.6ml Kwikpen contains Tirzepatide, which works by increasing insulin levels in the body, thereby helping control blood sugar levels. It also helps reduce appetite by delaying stomach emptying and promotes feelings of fullness.

Each KwikPen delivers four doses, offering convenient once-weekly administration for a full month's treatment. This medicine may cause side effects such as vomiting, nausea, abdominal pain, diarrhoea, headache, and allergic reactions. If these side effects persist or worsen, please consult your doctor.

Yurpeak 5 mg/0.6ml Kwikpen should be avoided if you are allergic to any of its components. Inform your doctor about your medical history and other conditions like liver/kidney disease, stomach problems, vision problems (retinopathy), pancreatitis, depression, and hypoglycemia.

Uses of Yurpeak 5 mg/0.6ml Kwikpen

Yurpeak 5 mg/0.6ml Kwikpen is used to treat type II diabetes and obesity. The detailed uses of Yurpeak 5 mg/0.6ml Kwikpen are as follows:

  • Treatment of Type II Diabetes Mellitus: Yurpeak 5 mg/0.6ml Kwikpen is used in the treatment of type II Diabetes Mellitus. It is a viable alternative for supplementing the incretin effect in achieving glycemic control, as this impact is weakened in diabetes, with the additional benefits of glycosylated haemoglobin (HbA1c) reduction.
  • Management of weight loss: Yurpeak 5 mg/0.6ml Kwikpen is used to manage weight loss in obese people. It helps prolong the sensation of fullness and thereby promotes weight loss, cardiovascular health, a good lipoprotein profile, and improvement in nonalcoholic steatohepatitis.

Key Benefits

  • Yurpeak 5 mg/0.6ml Kwikpen helps in effective blood sugar control in people with type 2 diabetes by enhancing the body’s natural insulin response.
  • It promotes significant weight loss by reducing appetite and slowing digestion, helping you feel full for longer.
  • It improves insulin sensitivity and reduces fat storage in the body.
  • Yurpeak 5 mg/0.6ml Kwikpen lowers the risk of diabetes-related complications, such as heart disease and nerve damage.
  • It supports long-term weight management and overall metabolic health when combined with a healthy diet and regular exercise.

Directions for Use

  • Follow your doctor's instructions on the dosage and timing of this medication.
  • Yurpeak 5 mg/0.6ml Kwikpen should be administered once a week. It should be injected subcutaneously in the abdomen, thigh, or upper arm.
  • Do not use Yurpeak 5 mg/0.6ml Kwikpen if you notice any particulate matter or discolouration.

How Yurpeak 5 mg/0.6ml Kwikpen Works

Yurpeak 5 mg/0.6ml Kwikpen contains Tirzepatide, which belongs to the class of GLP-1 receptor agonist. This medicine works by activating both GIP (glucose-dependent insulin polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors, thereby helping control blood sugar levels. In obese people, it slows gastric emptying and fosters a sense of fullness, leading to better weight loss. It also decreases hunger by delaying the stomach's emptying period and interacting with brain regions that contain GLP-1 receptors, indicating fullness.
bannner image

Alcohol

Unsafe

Avoid drinking alcohol as it can cause serious adverse effects.

bannner image

Pregnancy

Consult your doctor

If you are pregnant or planning pregnancy, inform your doctor before receiving Yurpeak 5 mg/0.6ml Kwikpen.

bannner image

Breast Feeding

Consult your doctor

If you are breastfeeding, inform your doctor before receiving Yurpeak 5 mg/0.6ml Kwikpen. Your doctor may prescribe this medicine if the benefits outweigh the risks.

bannner image

Driving

Safe if prescribed

Yurpeak 5 mg/0.6ml Kwikpen usually does not affect your ability to drive or operate machinery.

bannner image

Liver

Caution

Use Yurpeak 5 mg/0.6ml Kwikpen with caution, especially if you have a history of liver disease. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.

bannner image

Kidney

Caution

Use Yurpeak 5 mg/0.6ml Kwikpen with caution, especially if you have a history of kidney disease. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.

bannner image

Children

Unsafe

Yurpeak 5 mg/0.6ml Kwikpen is not recommended for children as the safety and effectiveness were not established.

bannner image

Heart

Safe if prescribed

Yurpeak 5 mg/0.6ml Kwikpen is generally considered safe for heart patients. However, please consult your doctor if you have any concerns.

bannner image

Geriatrics

Consult your doctor

Please consult your doctor before giving Yurpeak 5 mg/0.6ml Kwikpen to elderly people. Your doctor will prescribe Yurpeak 5 mg/0.6ml Kwikpen if the benefits outweigh the risk.

What if I have taken an overdose of Yurpeak 5 mg/0.6ml Kwikpen

Please do not exceed the recommended dose. An overdose of Yurpeak 5 mg/0.6ml Kwikpen may cause low blood sugar, stomach pains, feeling or being sick (nausea or vomiting), and feeling dizzy and worried. Seek immediate medical attention if you observe these symptoms or suspect that you might have taken an overdose.

Diet & Lifestyle Advise

  • Try doing 30 minutes of moderate-intensity physical activity or one hour and 15 minutes of high-intensity exercise weekly.
  • Include whole-grain foods, fruits, veggies and other fibre-enriched foods in your diet.
  • Add omega-3 fatty acid-containing oils for daily cooking.
  • Avoid too much stress, as it may elevate your blood sugar level. To control stress-related blood sugar changes, you can adopt stress management techniques like mindfulness, meditation, or yoga.
  • Loss of weight gradually to achieve a healthy body mass index (18.5 to 24.9).
  • Keep your blood pressure as normal (140/90) as possible, as it reduces the risk of cardiovascular diseases in diabetes patients.
  • Avoid smoking and alcohol consumption while on treatment with Yurpeak 5 mg/0.6ml Kwikpen.
  • Take short, frequent meals, and avoid prolonged fasting when taking Yurpeak 5 mg/0.6ml Kwikpen.

Health Queries

What are the latest advancements in diabetes treatments, and which medications do you suggest?

Dr. S Aneela

Dr. S Aneela

M. Pharm (Pharmacology)., PhD

Recent advances in diabetes treatment focus not only on lowering blood sugar but also on protecting the heart and kidneys. Newer medicines include GLP-1 Receptor Agonists, which can help control blood sugar and support weight loss, and SGLT2 Inhibitors, which help remove excess sugar through the urine and may provide heart and kidney benefits. Another newer option is Tirzepatide, which has shown strong effects in improving blood sugar control and promoting weight loss. However, the most suitable treatment depends on your blood sugar levels, kidney function, heart health, and other medical conditions. Please consult your doctor to determine which option is safest and most appropriate for you.
health query

Have a query?

How Soon It Starts Working

The time required for Yurpeak 5 mg/0.6ml Kwikpen to start to work: The time required for Yurpeak 5 mg/0.6ml Kwikpen to show its action is unknown.

The time for which the effects of Yurpeak 5 mg/0.6ml Kwikpen last: The duration of action for Yurpeak 5 mg/0.6ml Kwikpen is unknown.

What if you forget to take Yurpeak 5 mg/0.6ml Kwikpen

If you miss a dose, administer Yurpeak 5 mg/0.6ml Kwikpen as soon as possible within 4 days after the missed dose. If more than 4 days have passed, skip the missed dose and administer the next dose on your regularly scheduled day. In either case, you can resume your regular once-weekly dosing schedule.

Storage

• Store in a cool and dry place away from sunlight.• Keep Yurpeak 5 mg/0.6ml Kwikpen out of the sight and reach of children.• Cold chain - To be stored in cold places at 2ºC to 8ºC.

Keep Refrigerated. Do not freeze.Prepaid payment required.

Drug Warnings

  • Yurpeak 5 mg/0.6ml Kwikpen should be avoided if you are allergic to any of its components.
  • Before starting treatment, inform your doctor of your medical history and the medications you take, including any herbs or supplements. This can help prevent unwanted effects.
  • Yurpeak 5 mg/0.6ml Kwikpen is not recommended for use in patients with severe liver/kidney disease, type I diabetes, family history of MTC (medullary thyroid carcinoma) or in patients with multiple endocrine neoplasia syndrome type 2.
  • Consult your doctor if you are pregnant or breastfeeding.
  • It is not recommended for use in children below 18 years of age.
  • Caution should be exercised in conditions like liver/kidney disease, stomach problems, vision problems, pancreatitis, depression, gall bladder problems, malnutrition, and hypoglycemia.

verifiedApollotooltip

Drug-Drug Interactions: Yurpeak 5 mg/0.6ml Kwikpen interacts with an antidepressant (bupropion), drugs used to treat glaucoma, antibiotics (cephalexin, ciprofloxacin), anti-acidity drugs (cimetidine), heart condition drugs (digoxin), anti-epileptic drugs (topiramate, lamotrigine), and heart-related chest medicine (ranolazine).

Drug-Food Interactions:  Avoid intake of alcoholic beverages with Yurpeak 5 mg/0.6ml Kwikpen.

Drug-Disease Interactions: Inform your doctor if you have any liver/kidney disease, stomach problems, vision problems, pancreatitis, depression, gall bladder problems, or hypoglycaemia.

Login/Sign Up

verifiedApollotooltip

Login/Sign Up

All Substitutes & Brand Comparisons

Habit Forming

No

Therapeutic Class

[ANTIDIABETICS]

FAQs

Yurpeak 5 mg/0.6ml Kwikpen is used in the treatment of type II Diabetes Mellitus. It is a viable alternative for supplementing the incretin effect in achieving glycemic control, as this impact is weakened in diabetes, with the additional benefits of glycosylated haemoglobin (HbA1c) reduction. It is also used to manage weight loss in obese people. It helps prolong the sensation of fullness and thereby promotes weight loss, cardiovascular health, a good lipoprotein profile, and improvement in nonalcoholic steatohepatitis.
Yurpeak 5 mg/0.6ml Kwikpen contains Tirzepatide, which belongs to the class of GLP-1 receptor agonists. This medicine works by activating both GIP (glucose-dependent insulin polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors, thereby helping control blood sugar levels. In obese people, it slows gastric emptying and fosters a sense of fullness, leading to better weight loss. It also decreases hunger by delaying the stomach's emptying period and interacting with brain regions that contain GLP-1 receptors, indicating fullness.
If a dose of Yurpeak 5 mg/0.6ml Kwikpen is missed, give it as soon as possible within four days (96 hours); if more than four days have passed, skip the missed dose and return to your usual routine. If necessary, you can switch the day of weekly administration as long as there is a minimum of three days (72 hours) between the two doses.
Yurpeak 5 mg/0.6ml Kwikpen should be kept between 2°C and 8°C in the refrigerator. Avoid freezing or using it once frozen. Keep the medicine in its original container to keep it from light. Yurpeak 5 mg/0.6ml Kwikpen shouldn't be returned to the fridge if it has been kept at room temperature. If not utilized within 21 days of being removed from the refrigerator, discard.
Yurpeak 5 mg/0.6ml Kwikpen is not recommended to treat type 1 diabetes (your body produces no insulin). It is used in the treatment of only Type II diabetes (a chronic and lifelong condition wherein the body doesn’t use insulin effectively, which causes unusual blood glucose levels).
Yurpeak 5 mg/0.6ml Kwikpen can be taken with other diabetes medications if prescribed by the doctor. However, taking Yurpeak 5 mg/0.6ml Kwikpen with other diabetes medications may increase the risk of hypoglycaemia (low blood sugar). Therefore inform your doctor about your complete medication history before starting treatment with Yurpeak 5 mg/0.6ml Kwikpen.
Yurpeak 5 mg/0.6ml Kwikpen may cause serious adverse effects like thyroid C-cell tumours, pancreatitis, diabetic retinopathy complications, acute kidney injury, hypersensitivity, and acute gallbladder disease. Consult the doctor if you notice any unusual symptoms.
You should inform the doctor if you get eye problems, such as changes in vision, during treatment with this medicine as the Yurpeak 5 mg/0.6ml Kwikpen may lead to complications of diabetic eye disease (retinopathy). When taking this medication, you may feel nauseous, sick (vomiting), or have diarrhoea. These adverse effects may result in dehydration (loss of fluids). You must consume enough water to avoid dehydration, especially if you have kidney issues.
No, after taking your dose, you should throw away any leftover medication. The vial is only intended for one usage, and reusing leftover medicines may result in infection or improper dosage.
Yurpeak 5 mg/0.6ml Kwikpen is not recommended during pregnancy, as it is unknown if it affects your unborn baby. If you are pregnant or planning pregnancy, inform your doctor before taking Yurpeak 5 mg/0.6ml Kwikpen.
No, Yurpeak 5 mg/0.6ml Kwikpen is not an Insulin. It is a GLP-1 and GIP receptor agonist that slows digestion, lowers glucagon levels, and increases insulin release to control blood sugar. Unlike insulin, Mounjaro 5mg Solution for Injection improves the body's natural reaction to food intake rather than taking the place of insulin.
Yurpeak 5 mg/0.6ml Kwikpen is used to manage weight loss. Maintaining a proper diet and regular use of Yurpeak 5 mg/0.6ml Kwikpen can enhance weight loss. It depends on individual factors how much weight can be reduced in 3 months. If you have concerns, please consult your doctor.
Yurpeak 5 mg/0.6ml Kwikpen is administered as a weekly subcutaneous injection, which can be given in the abdomen, thigh, or upper arm. It should be injected on the same day each week, with or without food. To prevent irritation, change the injection site each time. Always use a fresh needle and syringe for each dose. Before using, ensure the solution is clear, colorless, and has not been frozen. Be sure to follow your doctor's guidance on the correct dosage and how to administer it.
Yurpeak 5 mg/0.6ml Kwikpen aids weight loss by reducing appetite and helping you feel full longer, which leads to eating less. It works by mimicking two natural hormones in the body—GLP-1 and GIP—that help control hunger, blood sugar, and digestion. These hormones help regulate appetite and metabolism, contributing to both weight loss and better blood sugar control.
Yurpeak 5 mg/0.6ml Kwikpen slows down the stomach's emptying, which may postpone the bloodstream's absorption of glucose. If this is used with a drug that causes hypoglycemia, this can result in dangerously low blood sugar levels.
Yurpeak 5 mg/0.6ml Kwikpen should not be used by anyone who has had MTC or a family member who has Type 2 of the Multiple Endocrine Neoplasia Syndrome (MEN-2). It should not be used in people under 18 years of age. Additionally, anyone who has experienced severe tirzepatide allergic responses should not use it. It should be avoided by patients who have a history of gastroparesis, severe gastrointestinal disorders, or pancreatitis since it may exacerbate these diseases. Under medical supervision, people with severe liver or renal illness should use it with caution.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.

Country of origin

Italy

Manufacturer/Marketer address

Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013.
Other Info - YUR0013
whatsapp Floating Button
Buy Now
Add to Cart